Hovione launches new website for the Chinese Market
Hovione is closer to its customers with a new website in Mandarin
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione is closer to its customers with a new website in Mandarin
Hovione is Growing
Scientist Live, 12 May 2025
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Its lead single-use nasal dry powder device now available for commercial partnerships
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally